This plain language summary explains the article ‘EGFR tyrosine kinase inhibitors for EGFR mutation-positive non-small-cell lung cancer: outcomes in Asian populations’ recently published in Future Oncology. The summary is intended to help people, including patients and their caregivers, patient advocates and healthcare professionals, learn about scientific discoveries and potential new therapeutic strategies for non-small cell lung cancer.
Read the full article here.
The original article, called ‘EGFR tyrosine kinase inhibitors for EGFR mutation-positive non-small-cell lung cancer: outcomes in Asian populations’ was published in the Future Oncology and can be read here.